Propanc Demonstrates Significant Anti-Tumor Efficacy in Pancreatic and Ovarian Cancer Preclinical Models; Files Patent Specifying New Therapeutic Target Dose Range 8:30 a.m. Nov. 17, 2015 - ACCESSWIRE ppch